Yasumichi Fukuda - Concepedia

Author

Yasumichi Fukuda

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Y. FUKUDA, Y. Fukuda, Yasumichi FUKUDA, Yasumichi Fukuda

Publications

923

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Sagami Chemical Research Institute United States Military Academy WuXi AppTec (China)

About

Yasumichi Fukuda is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	656
2	Natural Sciences	10	10	253
3	Biochemistry	9	9	350
4	Engineering	2	2	33
5	Health Sciences	2	2	169

Yasumichi Fukuda

Publications

892

Citations

H-Index

Page 1

	Year	Citations
Structures of Kibdelomycin Bound to <i>Staphylococcus aureus</i> GyrB and ParE Showed a Novel U-Shaped Binding Mode Jun Lu, Sangita B. Patel, Nandini Sharma, ACS Chemical Biology Atp-binding Site PocketMolecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial Pathogens	2014	141
Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents Sheo B. Singh, David E. Kaelin, Jin Wu, ACS Medicinal Chemistry Letters Antimicrobial ChemotherapyDrug ResistanceAm8191 BoundAntimicrobial TherapyAntibacterial Mechanisms	2014	75
Synthesis and Structure−Activity Relationship Studies of Highly Potent Novel Oxazolidinone Antibacterials Takashi Komine, Akihiko Kojima, Y. Asahina, Journal of Medicinal Chemistry BiochemistryMedicineAntibacterial ActivitySar TrendsPotent Antibacterial Activity	2008	72
Kibdelomycin Is a Bactericidal Broad-Spectrum Aerobic Antibacterial Agent Sheo B. Singh, Priya Dayananth, Carl J. Balibar, Antimicrobial Agents and Chemotherapy	2015	51
Synthetic studies on duocarmycin. 1. Total synthesis of dl-duocarmycin A and its 2-epimer Yasumichi Fukuda, Yoshio Itoh, Kazuhiko Nakatani, Tetrahedron Natural Product SynthesisSynthetic StudiesMedicineTotal SynthesisStereoselective Synthesis	1994	47
DNA alkylation properties of the duocarmycins: (+)-duocarmycin A, epi-(+)-duocarmycin A, ent-(−)-duocarmycin A and epi,ent-(−)-duocarmycin A Dale L. Boger, Weiya Yun, Shiro Terashima, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNucleic Acid ChemistryBioorganic ChemistryBiochemistryMolecular Biological Method	1992	47
Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2) Sheo B. Singh, David E. Kaelin, Jin Wu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntimicrobial Drug DiscoveryMedicineAntibiotic AdjuvantBroad-spectrum Antibacterial Agents-sar	2015	40
Synthesis and Antibacterial Activity of Novel Pyrido[1,2,3-<i>de</i>][1,4]benzoxazine-6-carboxylic Acid Derivatives Carrying the 3-Cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl Group as a C-10 Substituent Y. Asahina, Masaya Takei, Tetsuya Kimura, Journal of Medicinal Chemistry	2008	40
Novel Seco Cyclopropa[<i>c</i>]pyrrolo[3,2-<i>e</i>]indole Bisalkylators Bearing a 3,3‘-Arylenebisacryloyl Group as a Linker Yasumichi Fukuda, Shigeki Seto, Hirosuke Furuta, Journal of Medicinal Chemistry Compound 8Antitumor ActivityOrganic ChemistryChemistryHeterocycle Chemistry	2001	40
Novel Cyclopropapyrroloindole Derivative (AT-3510) Bearing Methoxycarbonyl and Trifluoromethyl Groups Yasumichi Fukuda, Hirosuke Furuta, Yoshie Kusama, Journal of Medicinal Chemistry Antitumor ActivityNovel Prodrug MctfcpiOrganic ChemistryPharmacotherapyChemistry	1999	35

Page 1